Results 121 to 130 of about 740 (167)

Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN. [PDF]

open access: yesBlood Neoplasia
Pemmaraju N   +9 more
europepmc   +1 more source

BPDCN: state of the art. [PDF]

open access: yesHematology Am Soc Hematol Educ Program
Pemmaraju N.
europepmc   +1 more source

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

open access: yesBlood Adv
Khalife-Hachem S   +15 more
europepmc   +1 more source

Outcomes of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm (BPDCN): a multicenter real-world analysis [Abstract]

open access: yes
Sauer, Tim   +24 more
core   +1 more source

Home - About - Disclaimer - Privacy